In addition, Fang et al. indicated that DSG2 was significantly overexpressed in ESCC [27]; however, serum DSG2 has not been demonstrated as a clinical biomarker in patients with ESCC and EJA. Here, DSG2 is linked to esophageal squamous cell carcinoma.